News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,148 Results
Type
Article (78523)
Company Profile (716)
Press Release (770882)
Multimedia
Podcasts (207)
Webinars (34)
Section
Business (228773)
Career Advice (3759)
Deals (39525)
Drug Delivery (162)
Drug Development (89998)
Employer Resources (206)
FDA (18214)
Job Trends (17252)
News (390309)
Policy (39047)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3033)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (174)
Alliances (56371)
ALS (207)
Alzheimer's disease (1883)
Antibody-drug conjugate (ADC) (415)
Approvals (18443)
Artificial intelligence (686)
Autoimmune disease (248)
Automation (52)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (219)
Biotechnology (443)
Bladder cancer (185)
Brain cancer (73)
Breast cancer (726)
Cancer (5621)
Cardiovascular disease (502)
Career advice (3229)
Career pathing (46)
CAR-T (328)
CDC (71)
Celiac Disease (2)
Cell therapy (887)
Cervical cancer (43)
Clinical research (76655)
Collaboration (2076)
Company closure (6)
Compensation (1296)
Complete response letters (91)
COVID-19 (3010)
CRISPR (110)
C-suite (1045)
Cystic fibrosis (159)
Data (7222)
Decentralized trials (3)
Denatured (77)
Depression (176)
Dermatology (59)
Diabetes (590)
Diagnostics (7394)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (336)
Drug pricing (234)
Drug shortages (37)
Duchenne muscular dystrophy (286)
Earnings (98547)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (135347)
Executive appointments (1107)
FDA (21760)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1724)
Gene editing (237)
Generative AI (67)
Gene therapy (742)
GLP-1 (1199)
Government (5454)
Grass and pollen (8)
Guidances (400)
Healthcare (20984)
HIV (80)
Huntington's disease (57)
IgA nephropathy (96)
Immunology and inflammation (325)
Immuno-oncology (91)
Indications (156)
Infectious disease (3355)
Inflammatory bowel disease (222)
Inflation Reduction Act (17)
Influenza (138)
Intellectual property (281)
Interviews (734)
IPO (17912)
IRA (61)
Job creations (5004)
Job search strategy (2608)
JPM (73)
Kidney cancer (19)
Labor market (104)
Layoffs (663)
Leadership (45)
Legal (9964)
Liver cancer (105)
Longevity (29)
Lung cancer (756)
Lymphoma (416)
Machine learning (54)
Management (66)
Manufacturing (989)
MASH (194)
Medical device (15117)
Medtech (15200)
Mergers & acquisitions (22777)
Metabolic disorders (1582)
mRNA (213)
Multiple sclerosis (182)
NASH (24)
Neurodegenerative disease (433)
Neuropsychiatric disorders (115)
Neuroscience (3403)
Neurotech (1)
NextGen: Class of 2026 (7666)
Non-profit (5129)
Now hiring (74)
Obesity (773)
Opinion (355)
Ovarian cancer (187)
Pain (247)
Pancreatic cancer (267)
Parkinson's disease (362)
Partnered (37)
Patents (577)
Patient recruitment (614)
Peanut (65)
People (66362)
Pharmaceutical (128)
Pharmacy benefit managers (35)
Phase 1 (23740)
Phase 2 (33393)
Phase 3 (25169)
Pipeline (7251)
Policy (368)
Postmarket research (3272)
Preclinical (10476)
Press Release (72)
Prostate cancer (290)
Psychedelics (61)
Radiopharmaceuticals (329)
Rare diseases (1109)
Real estate (7229)
Recruiting (81)
Regulatory (28925)
Reports (71)
Research institute (2749)
Resumes & cover letters (585)
Rett syndrome (33)
RNA editing (22)
RSV (95)
Schizophrenia (175)
Series A (292)
Series B (212)
Service/supplier (26)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (185)
Sponsored (52)
Startups (4283)
State (2)
Stomach cancer (21)
Supply chain (126)
Tariffs (101)
The Weekly (127)
Vaccines (1225)
Venture capital (111)
Weight loss (524)
Women's health (113)
Worklife (23)
Date
Today (179)
Last 7 days (742)
Last 30 days (3018)
Last 365 days (32356)
2026 (8353)
2025 (32530)
2024 (37883)
2023 (42566)
2022 (53928)
2021 (58722)
2020 (57663)
2019 (51307)
2018 (39084)
2017 (36875)
2016 (37814)
2015 (43829)
2014 (38596)
2013 (34727)
2012 (36660)
2011 (36671)
2010 (36192)
Location
Africa (1219)
Alabama (98)
Alaska (7)
Arizona (347)
Arkansas (15)
Asia (50673)
Australia (8703)
California (12726)
Canada (3585)
China (1324)
Colorado (546)
Connecticut (552)
Delaware (381)
Europe (115276)
Florida (1902)
Georgia (417)
Hawaii (4)
Idaho (68)
Illinois (1060)
India (86)
Indiana (593)
Iowa (24)
Japan (503)
Kansas (137)
Kentucky (50)
Louisiana (44)
Maine (85)
Maryland (1573)
Massachusetts (9300)
Michigan (379)
Minnesota (722)
Mississippi (7)
Missouri (153)
Montana (37)
Nebraska (30)
Nevada (142)
New Hampshire (89)
New Jersey (3433)
New Mexico (33)
New York (3360)
North Carolina (1727)
North Dakota (10)
Northern California (6206)
Ohio (388)
Oklahoma (25)
Oregon (52)
Pennsylvania (2538)
Puerto Rico (26)
Rhode Island (53)
South America (1586)
South Carolina (76)
South Dakota (1)
Southern California (4960)
Tennessee (204)
Texas (2023)
United States (45686)
Utah (383)
Vermont (1)
Virginia (325)
Washington D.C. (88)
Washington State (1050)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
850,148 Results for "renhe group development co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
November 6, 2025
·
3 min read
Rare diseases
Rare Disease Groups Lobby for Regulatory Expediency as Makary Defends ‘Rigorous’ Approach
This week’s Capitol Hill meetings come on the heels of rejections of ultra-rare disease drugs developed by Biohaven and Saol Therapeutics. Physicians and patient groups implored the FDA to expedite these treatments.
February 27, 2026
·
6 min read
·
Heather McKenzie
Press Releases
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
February 10, 2026
·
4 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Press Releases
MediKarma Acquires Nanell from Niterra Co., Ltd. to Accelerate Women’s Health Expansion and Value-Based Care Footprint
February 23, 2026
·
3 min read
Press Releases
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
February 25, 2026
·
5 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Press Releases
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
January 12, 2026
·
5 min read
Press Releases
WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer
December 29, 2025
·
4 min read
Press Releases
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan
December 15, 2025
·
3 min read
1 of 85,015
Next
